Malcolm Anders Smith
Impact in
- Rheumatology top 0.1%
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
-
- Acute Lymphoblastic Leukemia research
Papers in
- Rheumatology 115
- Rheumatoid Arthritis Research and Therapies 104
-
- Acute Lymphoblastic Leukemia research 82
- Co-authors
- Peter J. Houghton (116 shared papers)Michael J Ahern (70 shared papers)John M. Maris (79 shared papers)C. Patrick Reynolds (75 shared papers)Richard B. Lock (87 shared papers)Gregory H. Reaman (15 shared papers)Edward Anders Kolb (81 shared papers)Richard Greg Gorlick (79 shared papers)
- Journals
- Pediatric Blood & Cancer (86 papers)Blood (33 papers)Annals of the Rheumatic Diseases (20 papers)Journal of Clinical Oncology (19 papers)Clinical Cancer Research (18 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Malcolm Anders Smith
486 papers receiving 34.2k citations
Malcolm Anders Smith's Hit Papers
Peers
Comparison fields: 5 of 179
- Rheumatology 4.1k
- Public Health, Environmental and Occupational Health 8k
- Neurology 3.3k
- Genetics 2k
- Hematology 2.6k
Countries citing papers authored by Malcolm Anders Smith
This map shows the geographic impact of Malcolm Anders Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Anders Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Anders Smith more than expected).
Fields of papers citing papers by Malcolm Anders Smith
This network shows the impact of papers produced by Malcolm Anders Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Anders Smith. The network helps show where Malcolm Anders Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Malcolm Anders Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 500 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma Hit paper breakdown → | 2010 | 1437 |
| 2 | Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia Hit paper breakdown → | 2009 | 1179 |
| 3 | Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia Hit paper breakdown → | 2014 | 1125 |
| 4 | The genetic landscape of high-risk neuroblastoma Hit paper breakdown → | 2013 | 944 |
| 5 | Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century Hit paper breakdown → | 2010 | 845 |
| 6 | Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility Hit paper breakdown → | 2011 | 755 |
| 7 | Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Hit paper breakdown → | 1996 | 750 |
| 8 | The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia Hit paper breakdown → | 2017 | 727 |
| 9 | Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours Hit paper breakdown → | 2018 | 677 |
| 10 | The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions Hit paper breakdown → | 2017 | 636 |
| 11 | Study design and cohort characteristics of the childhood cancer survivor study: A multi‐institutional collaborative project Hit paper breakdown → | 2002 | 617 |
| 12 | Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia Hit paper breakdown → | 2012 | 582 |
| 13 | Selumetinib in Children with Inoperable Plexiform Neurofibromas Hit paper breakdown → | 2020 | 507 |
| 14 | Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia Hit paper breakdown → | 2010 | 487 |
| 15 | JAK mutations in high-risk childhood acute lymphoblastic leukemia Hit paper breakdown → | 2009 | 470 |
| 16 | Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. | 1997 | 465 |
| 17 | 2002 | 464 | |
| 18 | 1992 | 440 | |
| 19 | Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations Hit paper breakdown → | 2015 | 436 |
| 20 | 2014 | 426 |
About Malcolm Anders Smith
Malcolm Anders Smith is a scholar working on Rheumatology, Public Health, Environmental and Occupational Health, Oncology, Hematology and Pulmonary and Respiratory Medicine, having authored 500 papers that have together received 35.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (104 papers), Acute Lymphoblastic Leukemia research (82 papers), Sarcoma Diagnosis and Treatment (39 papers), Acute Myeloid Leukemia Research (24 papers), Glioma Diagnosis and Treatment (17 papers), Statistical Methods in Clinical Trials (15 papers), Systemic Sclerosis and Related Diseases (13 papers) and Cancer therapeutics and mechanisms (13 papers). The work is most often cited by research in Rheumatology (4.1k citations), Public Health, Environmental and Occupational Health (8k citations), Neurology (3.3k citations), Genetics (2k citations) and Hematology (2.6k citations). Malcolm Anders Smith has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Peter J. Houghton, Michael J Ahern, John M. Maris, C. Patrick Reynolds, Richard B. Lock, Gregory H. Reaman, Edward Anders Kolb, Richard Greg Gorlick, Stephen Thomas Keir and Lynn A. G. Ries. Their work appears in journals such as Pediatric Blood & Cancer, Blood, Annals of the Rheumatic Diseases, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.